Bionexus Gene Lab CORP (BGLC) — 8-K Filings

All 8-K filings from Bionexus Gene Lab CORP. Browse 28 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (28)

8-K Filing — Dec 30, 2025
BioNexus Gene Lab Corp Files 8-K — Dec 23, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on December 23, 2025, reporting an event that occurred on December 19, 2025. The filing is categorized under 'Other Events'
8-K Filing — Dec 2, 2025
8-K Filing — Nov 13, 2025
BioNexus Gene Lab Corp. Files 8-K with Key Agreements and Sales — Nov 12, 2025 Risk: medium
BioNexus Gene Lab Corp. filed an 8-K on November 12, 2025, reporting on several key events. These include entering into a material definitive agreement, unregis
BioNexus Gene Lab Corp Files 8-K — Oct 23, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on October 23, 2025, reporting events as of October 20, 2025. The filing primarily concerns Regulation FD Disclosure and in
BioNexus Gene Lab Corp. Files 8-K — Jul 30, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on July 30, 2025, reporting under Regulation FD and including financial statements and exhibits. The company, incorporated
BioNexus Gene Lab Corp. Elects New Directors — Jun 23, 2025 Risk: medium
BioNexus Gene Lab Corp. announced on June 17, 2025, a change in its board of directors. The company elected two new directors, Mr. Jianjun Li and Mr. Jianjun Li
BioNexus Gene Lab Corp. Faces Delisting Concerns — Apr 30, 2025 Risk: high
BioNexus Gene Lab Corp. filed an 8-K on April 30, 2025, to report its notice of delisting or failure to satisfy a continued listing rule or standard, along with
BioNexus Gene Lab Corp. Files 8-K on Security Holder Rights — Apr 10, 2025 Risk: medium
BioNexus Gene Lab Corp. filed an 8-K on April 10, 2025, reporting a material modification to the rights of its security holders as of April 7, 2025. The filing
BioNexus Gene Lab Corp Files 8-K on Corporate Changes — Apr 3, 2025 Risk: medium
BioNexus Gene Lab Corp. filed an 8-K on April 3, 2025, reporting material modifications to security holder rights and amendments to its articles of incorporatio
BioNexus Gene Lab Corp. Files 8-K on Shareholder Vote Matters — Mar 25, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on March 25, 2025, reporting a submission of matters to a vote of security holders on March 19, 2025. The company, incorpor
BioNexus Gene Lab Corp. Files 8-K — Mar 7, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on March 7, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the compan
BioNexus Gene Lab Corp. Files 8-K — Mar 5, 2025 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on March 5, 2025, reporting other events and financial statements. The company, incorporated in Wyoming, is based in Kuala
BioNexus Gene Lab Corp. Files 8-K on Equity Sales & Bylaw Changes — Feb 14, 2025 Risk: medium
BioNexus Gene Lab Corp. filed an 8-K on February 14, 2025, reporting on unregistered sales of equity securities and material modifications to security holder ri
BioNexus Gene Lab Corp. Faces Delisting Concerns — Jan 2, 2025 Risk: high
BioNexus Gene Lab Corp. filed an 8-K on January 2, 2025, reporting a notice of delisting or failure to meet continued listing standards as of December 27, 2024.
BioNexus Gene Lab Corp. Faces Delisting Concerns — Nov 8, 2024 Risk: high
BioNexus Gene Lab Corp. filed an 8-K on November 8, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The filing also covers
BioNexus Gene Lab Corp. Reports Board and Officer Changes — Oct 15, 2024 Risk: medium
BioNexus Gene Lab Corp. announced on October 9, 2024, a change in its board of directors. The company filed an 8-K report detailing the departure of certain off
BioNexus Gene Lab Corp. Files 8-K on Corporate Matters — Oct 10, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on October 10, 2024, reporting on matters submitted to a vote of security holders and other events that occurred on October
BioNexus Gene Lab Corp. Files 8-K for Material Agreement — Sep 25, 2024 Risk: medium
BioNexus Gene Lab Corp. announced on September 25, 2024, that it entered into a material definitive agreement on September 23, 2024. The company, incorporated i
BioNexus Gene Lab Corp Files 8-K — Sep 18, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on September 18, 2024, reporting an event that occurred on September 14, 2024. The filing is a current report pursuant to S
BioNexus Gene Lab Corp Files 8-K — Sep 12, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on September 12, 2024, reporting an event on September 11, 2024. The filing is categorized under Regulation FD Disclosure a
BioNexus Gene Lab Corp. Files 8-K, Changes Fiscal Year — Sep 5, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on September 5, 2024, reporting a change in its fiscal year end to December 31st. This filing also includes financial state
BioNexus Gene Lab Corp Files 8-K — Aug 28, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on August 28, 2024, reporting events as of August 27, 2024. The filing primarily concerns Regulation FD Disclosure and incl
BioNexus Gene Lab Corp. Enters Material Definitive Agreement — Aug 26, 2024 Risk: medium
BioNexus Gene Lab Corp. announced on August 26, 2024, that it has entered into a material definitive agreement. The company, incorporated in Wyoming with its pr
BioNexus Gene Lab Corp. Faces Delisting Notice — May 9, 2024 Risk: high
BioNexus Gene Lab Corp. filed an 8-K on May 8, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company is incorporated
BioNexus Gene Lab Corp Files 8-K — Apr 18, 2024 Risk: low
BioNexus Gene Lab Corp. filed an 8-K on April 18, 2024, to report on other events and financial statements. The filing details the company's incorporation in Wy
BioNexus Gene Lab Corp. Files 8-K on Officer/Director Changes — Apr 1, 2024 Risk: medium
BioNexus Gene Lab Corp. filed an 8-K on March 26, 2024, reporting on the departure of directors or certain officers, the election of directors, the appointment

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX